Attached files

file filename
8-K - 8-K - SPARTON CORPq2fy2018earningsrelease-8k.htm


 
 
Media Contact:
 
Joe McCormack
 
 
 
 
Sparton Corporation
 
 
 
 
Email: ir@sparton.com
 
 
 
 
Office: (847) 762-5800
FOR IMMEDIATE RELEASE
Sparton Corporation Reports Fiscal 2018 Second Quarter Results
SCHAUMBURG, IL. - February 6, 2018 - Sparton Corporation (NYSE: SPA) today announced results for the second quarter of fiscal year 2018 ended December 31, 2017.
Second Quarter Financial Results and Highlights
Joseph J. Hartnett, Interim President & CEO, commented, “The operational improvements we have made over the past two years continues to drive our performance through some very challenging times. Thanks to the collective effort of the entire organization, we were able to achieve significant improvements over our first quarter’s results in many important areas including sales, margins, cash flows, new program wins and borrowings under our credit facility."
Joseph G. McCormack, Senior Vice President & CFO, commented, “During the second quarter of fiscal year 2018, the Company recorded additional income tax expense of $10.8 million as a result of the newly enacted Tax Cuts and Jobs Act of 2017 which was principally related to a write-down of the Company’s net deferred tax assets as a result of the reduction in the statutory income tax rate.”
Consolidated:
• Net sales of $97.8 million
• Gross profit margin of 20.9%
• SG&A expenses of $14.1 million or 14.4% of sales; adjusted SG&A of $12.7 million, 13.0% of sales
• Loss per share of $(0.92), adjusted earnings per share of $0.45
• Adjusted EBITDA of $8.7 million, an 8.9% adjusted EBITDA margin
MDS Segment:
• Gross sales of $58.4 million
• Gross profit margin of 12.6%
• Operating loss of $0.2 million
• Adjusted EBITDA of $4.2 million, a 7.1% adjusted EBITDA margin
• New program wins in Q2 have expected revenue of $20.0 million when fully ramped up into production
• Trailing four quarter new program win revenue of $67.4 million, which continues to support our future organic growth
ECP Segment:
• Gross sales of $42.5 million
• Gross profit margin of 31.7%
• Operating income of $8.9 million
• Adjusted EBITDA of $10.5 million, a 24.6% adjusted EBITDA margin

SELECTED FINANCIAL DATA
 
For the Quarters Ended
 
For the First Two Quarters
 
Q2 FY18
 
Q1 FY18
 
Q2 FY17
 
2018
 
2017
 
(Dollars in thousands, except per share data)
Consolidated:
 
 
 
 
 
 
 
 
 
Net sales
$
97,819

 
$
82,763

 
$
97,399

 
$
180,582

 
$
197,766

Gross profit
20,429

 
14,588

 
15,898

 
35,017

 
33,183

Selling and administrative expenses
14,074

 
15,205

 
12,953

 
29,279

 
26,336

Operating income
3,793

 
(3,112
)
 
221

 
681

 
1,553

Adjusted operating income (non-GAAP)
7,053

 
1,162

 
3,107

 
8,215

 
7,421

Earnings per share
(0.92
)
 
(0.29
)
 
(0.09
)
 
(1.21
)
 
(0.08
)
Adjusted Earnings per share (non-GAAP)
0.45

 

 
0.10

 
0.44

 
0.31

EBITDA (non-GAAP)
7,153

 
337

 
3,890

 
7,490

 
8,961

Adjusted EBITDA (non-GAAP)
8,741

 
2,899

 
5,553

 
11,640

 
11,696

Adjusted EBITDA margin (non-GAAP)
8.9
%
 
3.5
%
 
5.7
%
 
6.4
%
 
5.9
%
Free cash flow (non-GAAP)
$
19,725

 
$
(23,684
)
 
$
10,008

 
$
(3,959
)
 
$
12,101

 
 
 
 
 
 
 
 
 
 
MDS Segment:
 
 
 
 
 
 
 
 
 
Gross sales
$
58,353

 
$
55,308

 
$
67,382

 
$
113,661

 
$
132,384

Intercompany sales
(2,970
)
 
(2,937
)
 
(2,333
)
 
(5,907
)
 
(4,533
)
Net sales
55,383

 
52,371

 
65,049

 
107,754

 
127,851

Gross profit
6,960

 
5,993

 
8,357

 
12,953

 
15,651

Selling and administrative expenses
3,513

 
3,454

 
3,384

 
6,967

 
6,892

Allocation of corporate expenses
2,101

 
2,446

 
2,177

 
4,547

 
4,645

Operating Income (loss)
(208
)
 
(1,485
)
 
986

 
(1,693
)
 
472

Adjusted Segment EBITDA (non-GAAP)
$
4,159

 
$
3,250

 
5,875

 
$
7,409

 
$
10,566

 
 
 
 
 
 
 
 
 
 
ECP Segment:
 
 
 
 
 
 
 
 
 
Gross sales
$
42,468

 
$
30,399

 
$
32,350

 
$
72,867

 
$
69,942

Intercompany sales
(32
)
 
(7
)
 

 
(39
)
 
(27
)
Net sales
42,436

 
30,392

 
32,350

 
72,828

 
69,915

Gross profit
13,469

 
8,595

 
7,541

 
22,064

 
17,532

Selling and administrative expenses
2,533

 
2,589

 
2,550

 
5,122

 
5,174

Allocation of corporate expenses
1,037

 
991

 
995

 
2,028

 
2,195

Operating Income
8,891

 
4,098

 
3,082

 
12,989

 
8,511

Adjusted Segment EBITDA (non-GAAP)
$
10,458

 
$
5,678

 
4,646

 
16,136

 
$
11,874

Liquidity and Capital Resources
As of December 31, 2017, the Company had $42 million available under its $125 million credit facility.
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (“GAAP”), Sparton Corporation has provided certain non-GAAP financial measures as additional information for its operating results. These measures have not been prepared in accordance with GAAP and may be different from measures used by other companies. Whenever we use non-GAAP financial measures, we designate these measures, which exclude the effects of certain expenses and income, as “adjusted” and provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. The non-GAAP financial measures eliminate or add certain items of expense and income from total operating expense and income taxes. Management believes that this presentation is helpful to investors in evaluating the current operational and financial performance of our business and facilitates comparisons to historical results of operations. Management discloses this information along with a reconciliation of the comparable GAAP amounts to provide access to the detail and nature of adjustments made to GAAP financial results. While some of these excluded items have been periodically reported in our statements of operations, their occurrence in future periods depends on future business and economic factors, among other evaluation criteria, and the occurrence of such events and factors may frequently be beyond the control of management.
When we calculate adjusted earnings per share, adjusted EBITDA and other adjustments to the statements of income, we exclude certain expenses and income because we believe that they are not related directly to the underlying performance of our fundamental business operations. We exclude these measures when reviewing financial results and for business planning. Although these events are reflected in our GAAP financial statements, these transactions may limit the comparability of our fundamental operations with prior and future periods. We believe EBITDA and adjusted EBITDA are commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. The Company does not intend, nor should the reader consider, EBITDA or adjusted EBITDA to be an alternative to operating income, net income, net cash provided by operating activities or any other items calculated in accordance with GAAP. The Company's definition of adjusted EBITDA may not be comparable with other companies. Accordingly, the measurement has limitations depending on its use.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 118th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has thirteen manufacturing locations and engineering design centers worldwide. Sparton's Web site may be accessed at www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10-K and Form 10-Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.

1



CONSOLIDATING FINANCIAL INFORMATION - Q2 FISCAL YEAR 2018
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
55,383

 
$
42,436

 
$
97,819

Cost of goods sold

 
48,423

 
28,967

 
77,390

Gross profit

 
6,960

 
13,469

 
$
20,429

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
8,028

 
3,513

 
2,533

 
14,074

Selling and administrative - Corp allocations
(3,138
)
 
2,101

 
1,037

 

Internal research and development

 

 
669

 
669

Amortization of intangible assets

 
1,554

 
339

 
1,893

Total operating expenses
4,890

 
7,168

 
4,578

 
16,636

Income (loss) from operations
(4,890
)
 
(208
)
 
8,891

 
3,793

Interest expense, net
(1,507
)
 

 

 
(1,507
)
Other income (expense)
(1
)
 
19

 
(5
)
 
13

Income taxes
(11,296
)
 
(37
)
 

 
(11,333
)
Net income (loss)
$
(17,694
)
 
$
(226
)
 
$
8,886

 
$
(9,034
)
Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
(0.92
)
Diluted
 
 
 
 
 
 
(0.92
)
Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,834,723

Diluted
 
 
 
 
 
 
9,834,723


CONSOLIDATING FINANCIAL INFORMATION - Q2 FISCAL YEAR 2017
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
65,049

 
$
32,350

 
$
97,399

Cost of goods sold

 
56,692

 
24,809

 
81,501

Gross profit

 
8,357

 
7,541

 
$
15,898

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
7,019

 
3,384

 
2,550

 
12,953

Selling and administrative - Corp allocations
(3,172
)
 
2,177

 
995

 

Internal research and development

 

 
533

 
533

Amortization of intangible assets

 
1,810

 
381

 
2,191

Total operating expenses
3,847

 
7,371

 
4,459

 
15,677

Income (loss) from operations
(3,847
)
 
986

 
3,082

 
221

Interest expense, net
(1,071
)
 
4

 

 
(1,067
)
Other income (expense)
(7
)
 
12

 
(16
)
 
(11
)
Income taxes
(45
)
 
(5
)
 

 
(50
)
Net income (loss)
$
(4,970
)
 
$
997

 
$
3,066

 
$
(907
)
Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
(0.09
)
Diluted
 
 
 
 
 
 
(0.09
)
Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,802,664

Diluted
 
 
 
 
 
 
9,802,664


2



CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

 
For the First Two Quarters
 
2018
 
2017
 
($ in thousands)
Cash Flows from Operating Activities:
 
 
 
Operating activities, net of working capital changes
$
5,891

 
$
8,158

Net changes in working capital
(6,765
)
 
6,513

Cash Flows from Operating Activities
(874
)
 
14,671

Cash Flows from Investing Activities:
 
 
 
Capital expenditures
(3,099
)
 
(2,570
)
Other investing activities
14

 

Cash Flows from Investing Activities
(3,085
)
 
(2,570
)
Cash Flows from Financing Activities:
 
 
 
Net change in credit facility
4,400

 
(11,500
)
Other financing activities
(325
)
 
(144
)
Cash Flows from Financing Activities
4,075

 
(11,644
)
Change in Cash and Cash Equivalents
116

 
457

 
 
 
 
Cash and Cash Equivalents - Beginning
988

 
132

Cash and Cash Equivalents - Ending
$
1,104

 
$
589



CONDENSED CONSOLIDATED BALANCE SHEETS
 
December 31,
2017
 
July 2,
2017
 
($ in thousands)
Assets
 
 
 
Cash and cash equivalents
$
1,104

 
$
988

Accounts receivable, net
54,466

 
45,347

Inventories
62,767

 
60,248

Prepaid and other current assets
4,177

 
3,851

Property, plant and equipment, net
34,484

 
34,455

Goodwill
12,663

 
12,663

Other intangible assets, net
24,629

 
28,445

Other assets
19,948

 
31,146

Total assets
$
214,238

 
$
217,143

Liabilities and Shareholders’ Equity
 
 
 
Accounts payable
$
38,210

 
$
27,672

Accrued expenses
20,807

 
26,580

Credit facility
78,900

 
74,500

Capital lease obligations, long term
32

 
167

Environmental
5,208

 
5,468

Pension
820

 
888

Shareholders’ Equity
70,261

 
81,868

Total Liabilities and Shareholders’ Equity
$
214,238

 
$
217,143


3



RECONCILIATION OF NON-GAAP MEASURES

EBITDA Reconciliation (Non-GAAP) - Q2 Fiscal Year 2018
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(17,694
)
 
$
(226
)
 
$
8,886

 
$
(9,034
)
Interest expense, net
1,507

 

 

 
1,507

Income taxes
11,296

 
37

 

 
11,333

Amortization of intangible assets

 
1,554

 
339

 
1,893

Depreciation
565

 
693

 
196

 
1,454

Selling and administrative - Corp allocations
(3,138
)
 
2,101

 
1,037

 

EBITDA, excluding corporate allocation
(7,464
)
 
4,159

 
10,458

 
7,153

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Stock-based compensation
221

 

 

 
221

Costs related to potential sale of Company
1,367

 

 

 
1,367

Adjusted EBITDA, before corporate allocation
$
(5,876
)
 
$
4,159

 
$
10,458

 
$
8,741

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(2,738
)
 
$
2,058

 
$
9,421

 
$
8,741

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
8.9
%

EBITDA Reconciliation (Non-GAAP) - Q2 Fiscal Year 2017
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(4,970
)
 
$
997

 
$
3,066

 
$
(907
)
Interest expense, net
1,071

 
(4
)
 

 
1,067

Income taxes
45

 
5

 

 
50

Amortization of intangible assets

 
1,810

 
381

 
2,191

Depreciation included in SG&A above
446

 
839

 
204

 
1,489

Selling and administrative - Corp allocations
(3,172
)
 
2,177

 
995

 

EBITDA, excluding corporate allocation
(6,580
)
 
5,824

 
4,646

 
3,890

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Stock-based compensation
968

 

 

 
968

Costs related to potential sale of company
644

 
51

 

 
695

Adjusted EBITDA, before corporate allocation
$
(4,968
)
 
$
5,875

 
$
4,646

 
$
5,553

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(1,796
)
 
$
3,698

 
$
3,651

 
$
5,553

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
5.7
%


4



Adjusted EPS (Non-GAAP)
 
For the Quarters Ended
 
For the First Two Quarters
 
Q2 FY18
 
Q1 FY18
 
Q2 FY17
 
2018
 
2017
 
(Dollars in thousands, except per share data)
Earnings per share - diluted, as reported
$
(0.92
)
 
$
(0.29
)
 
$
(0.09
)
 
$
(1.21
)
 
$
(0.08
)
Nonrecurring items
0.12

 
0.16

 
0.05

 
0.27

 
0.10

Amortization of intangible assets
0.15

 
0.13

 
0.14

 
0.28

 
0.29

Deferred tax asset adjustment
1.10

 

 

 
1.10

 

Adjusted earnings per share
$
0.45

 
$

 
$
0.10

 
$
0.44

 
$
0.31

 
 
 
 
 
 
 
 
 
 
Adjustments, net of tax:
 
 
 
 
 
 
 
 
 
Costs related to potential sale of Company
$
1,149

 
$
1,528

 
$
452

 
$
2,677

 
$
883

Other nonrecurring adjustments

 

 

 

 
65

Total nonrecurring, net of tax
1,149

 
1,528

 
452

 
2,677

 
948

Amortization of intangible assets, net of tax
1,498

 
1,250

 
1,424

 
2,748

 
2,866

Adjustments for Tax Act
10,807

 

 

 
10,807

 

Total adjustments
$
13,454

 
$
2,778

 
$
1,876

 
$
16,232

 
$
3,814



5



Adjusted SG&A and Operating Income (Non-GAAP)
 
For the Quarters Ended
 
Q2 FY18
 
Q1 FY18
 
Q2 FY17
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
(Dollars in thousands)
As reported
$
14,074

 
$
3,793

 
$
15,205

 
$
(3,112
)
 
$
12,953

 
$
221

Percentage of sales
14.4
%
 
3.9
%
 
18.4
%
 
(3.8
)%
 
13.3
%
 
0.2
%
Adjustments:
 
 
 
 
 
 
 
 
 
 
 
Amortization of intangible assets

 
1,893

 

 
1,923

 

 
2,191

Costs related to potential sale of Company
1,367

 
1,367

 
2,351

 
2,351

 
695

 
695

Other nonrecurring adjustments

 

 

 

 

 

     Total adjustments
1,367

 
3,260

 
2,351

 
4,274

 
695

 
2,886

As adjusted
$
12,707

 
$
7,053

 
$
12,854

 
$
1,162

 
$
12,258

 
$
3,107

 
 
 
 
 
 
 
 
 
 
 
 
Adjusted percentage of sales
13.0
%
 
7.2
%
 
15.5
%
 
1.4
 %
 
12.6
%
 
3.2
%


 
For the First Two Quarters
 
2018
 
2017
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
(Dollars in thousands)
As reported
$
29,279

 
$
681

 
$
26,336

 
$
1,553

Percentage of sales
16.2
%
 
0.4
%
 
13.3
%
 
0.8
%
Adjustments:
 
 
 
 
 
 
 
Amortization of intangible assets

 
3,816

 

 
4,410

Costs related to potential sale of Company
3,718

 
3,718

 
1,358

 
1,358

Other nonrecurring adjustments

 

 
100

 
100

     Total adjustments
3,718

 
7,534

 
1,458

 
5,868

As adjusted
$
25,561

 
$
8,215

 
$
24,878

 
$
7,421

 
 
 
 
 
 
 
 
Adjusted percentage of sales
14.2
%
 
4.5
%
 
12.6
%
 
3.8
%


6